Over-Expression of Egfr is Closely Correlated to Poor Prognosis in Tunisian Patients with Non-Small Cell Lung Adenocarcinoma

Author：              

Publisher： Taylor & Francis Ltd

ISSN： 1532-1819

Source： Journal of Immunoassay and Immunochemistry, Vol.35, Iss.3, 2014-07, pp. : 256-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Association of EGFR mutations with low BRCA1 gene expression in non-small cell lung cancer

By Li   Xie   Lai  

Molecular and Clinical Oncology, Vol. 1, Iss. 1, 2013-01 ,pp. : 195-199

Spandidos Publications

Access to resources Recommend Favorite

Small RNAs and Non-Small Cell Lung Cancer

By  

Current Molecular Medicine, Vol. 6, Iss. 3, 2006-05 ,pp. : 339-349

Bentham Science Publishers

Access to resources Recommend Favorite

PD1 gene promoter polymorphisms correlate with a poor prognosis in nonsmall cell lung cancer

By            

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1035-1042

Spandidos Publications

Access to resources Recommend Favorite

Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients

By                      

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 714-718

Spandidos Publications

Access to resources Recommend Favorite

Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC)

By Bellezza Guido   Sordo Rachele   Colella Renato   Ludovini Vienna   Ragusa Mark   Bianconi Fortunato   Ferri Ivana   Borri Filippo   Chiari Rita   Puma Francesco   Crinò Lucio   Sidoni Angelo  

Virchows Archiv, Vol. 463, Iss. 5, 2013-11 ,pp. : 663-671

Springer Publishing Company

Access to resources Recommend Favorite